Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025)

Beta Bionics' Asset Writedowns and Impairment history spans 2 years, with the latest figure at $16000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 38.46% year-over-year to $16000.0; the TTM value through Dec 2025 reached $40000.0, down 42.86%, while the annual FY2025 figure was $40000.0, 42.86% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $16000.0 at Beta Bionics, down from $24000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $27000.0 in Q2 2024 and bottomed at $16000.0 in Q4 2025.